Newgenivf Group Ltd. (NIVF) at a glance
Newgenivf Group Ltd. (NIVF) is a micro-cap Healthcare company. It trades at $0.42, with a P/E of 0, a 209% profit margin and revenue growth of 11.9%. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Value (99/100) and its weakest is Momentum (12/100). It is a relatively defensive holding with below-market volatility.
- Price
- $0.42
- Market cap
- $2.7M
- P/E ratio
- 0.0
- Dividend yield
- None
- Beta
- -0.00
- 52-week range
- $0.40 to $171.00
Value
99
Growth
62
Income
40
Safety
66
Momentum
12
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,165.75-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$269.47+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.05-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$377.10-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$150.37-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.12+0.92%
2.16% yield
AMGN65
Amgen Inc.
$392.00-1.05%
2.76% yield